title: Establishment of functional telomerase immortalized human hepatocytes and a hepatic stellate cell line for telomere-targeting anticancer drug development.
abstract: We previously reported that the telomere-targeting drug telomestatin induces apoptosis accompanied by G-tail reduction and dissociation of binding protein TRF2 from telomeres in cancer cell lines but not normal or human telomerase reverse transcriptase (hTERT)-immortalized cells. Because telomere-targeting drugs induce growth arrest in normal cells at higher doses, their development is dependent on the ability to predict toxicity before in vivo use, but no models for this are available. Here, we established two new cell lines, telomerase immortalized human fetal hepatocytes, Hc3716-hTERT, and telomerase immortalized hepatic stellate cells, NPC-hTERT. Examinations showed that Hc3716-hTERT maintained normal mammalian cell morphology, cell growth, albumin expression, and wild-type p53 responsiveness, whereas NPC-hTERT maintained hepatic stellate-like morphology, expression of hepatic stellate markers, alpha-smooth muscle actin, and secretion of type I collagen, an extracellular matrix protein. Given our finding that telomere G-tail length in Hc3716 cells was decreased in senescence and increased by hTERT infection, we next examined the effect of high-dose telomestatin-induced telomere dysfunction and G-tail shortening on cellular functions in Hc3716-hTERT cells. Interestingly, telomestatin decreased expression of cytochrome P450 (CYP) family members CYP3A3/4, CYP3A5, and CYP3A7, mRNA and induced albumin expression at both mRNA and protein levels. These gene expression responses to telomestatin were similar to those of the normal parental cell Hc3716. These established cell lines thus represent the first model for predicting the side-effects of telomere-targeting drugs in normal cells, and should be powerful tools in the development of these drugs.
authors.affiliation: Division of Frontier Medical Science Programs for Biomedical Research, Department of Medicine and Molecular Science, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan.
authors.forename: Koji
authors.initials: K
authors.lastname: Waki
authors.forename: Kumiko
authors.initials: K
authors.lastname: Anno
authors.forename: Taeko
authors.initials: T
authors.lastname: Ono
authors.forename: Toshinori
authors.initials: T
authors.lastname: Ide
authors.forename: Kazuaki
authors.initials: K
authors.lastname: Chayama
authors.forename: Hidetoshi
authors.initials: H
authors.lastname: Tahara
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology / Q000633:toxicity; D002455:Cell Division; D045744:Cell Line, Tumor; D005333:Fetus; D005784:Gene Amplification; D055166:Hepatic Stellate Cells / Q000187:drug effects / Q000201:enzymology*; D022781:Hepatocytes / Q000187:drug effects / Q000201:enzymology* / Q000821:virology; D006801:Humans; D010080:Oxazoles / Q000494:pharmacology / Q000633:toxicity; D012313:RNA / Q000235:genetics / Q000302:isolation & purification; D012333:RNA, Messenger / Q000235:genetics; D012190:Retroviridae / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D019098:Telomerase / Q000187:drug effects / Q000235:genetics* / Q000378:metabolism; D016615:Telomere / Q000187:drug effects / Q000502:physiology* / Q000648:ultrastructure; D014161:Transduction, Genetic
chemical_list: D000970:Antineoplastic Agents; D010080:Oxazoles; D012333:RNA, Messenger; C431888:telomestatin; D012313:RNA; C509186:TERT protein, human; D019098:Telomerase
references.citation: Nat Rev Mol Cell Biol. 2004 Apr;5(4):323-9
references.pmid: 15071557
references.citation: Hepatology. 2003 Nov;38(5):1095-106
references.pmid: 14578848
references.citation: Semin Liver Dis. 2001 Aug;21(3):351-72
references.pmid: 11586465
references.citation: Nat Genet. 1998 Jan;18(1):65-8
references.pmid: 9425903
references.citation: Science. 1998 Jan 16;279(5349):349-52
references.pmid: 9454332
references.citation: Arch Biochem Biophys. 1985 Aug 15;241(1):275-80
references.pmid: 4026319
references.citation: Biochem Biophys Res Commun. 1999 Mar 5;256(1):184-91
references.pmid: 10066444
references.citation: Mol Cell Biol. 2005 Mar;25(6):2158-68
references.pmid: 15743814
references.citation: Gastroenterology. 2003 Feb;124(2):432-44
references.pmid: 12557149
references.citation: Biochem Biophys Res Commun. 2007 Feb 23;353(4):926-32
references.pmid: 17207773
references.citation: Arch Biochem Biophys. 1989 Jan;268(1):144-51
references.pmid: 2492179
references.citation: Oncogene. 2002 Jan 21;21(4):532-40
references.pmid: 11850778
references.citation: Oncogene. 2006 Mar 23;25(13):1955-66
references.pmid: 16302000
references.citation: Nat Methods. 2005 Nov;2(11):829-31
references.pmid: 16278652
references.citation: Nat Genet. 2003 Apr;33(4):492-6
references.pmid: 12652299
references.citation: Cell. 1982 May;29(1):245-55
references.pmid: 6286143
references.citation: Lab Invest. 2002 Jun;82(6):719-28
references.pmid: 12065682
references.citation: Semin Liver Dis. 2001 Aug;21(3):337-49
references.pmid: 11586464
references.citation: Annu Rev Biochem. 1996;65:337-65
references.pmid: 8811183
references.citation: Cell. 1997 Mar 7;88(5):657-66
references.pmid: 9054505
references.citation: Gut. 2005 Jan;54(1):142-51
references.pmid: 15591520
references.citation: J Am Chem Soc. 2001 Feb 14;123(6):1262-3
references.pmid: 11456694
references.citation: Cancer Res. 1995 Jul 1;55(13):2734-6
references.pmid: 7796395
references.citation: Clin Chem. 1999 Oct;45(10):1718-24
references.pmid: 10508116
references.citation: FASEB J. 1999 Nov;13(14):1883-900
references.pmid: 10544172
references.citation: Cell Transplant. 2008 Sep;17(9):1083-1094
references.pmid: 28863749
references.citation: Oncogene. 2003 Aug 14;22(34):5338-47
references.pmid: 12917635
references.citation: Lab Invest. 1995 Jun;72(6):731-9
references.pmid: 7540235
references.citation: J Biol Chem. 2000 Jan 28;275(4):2247-50
references.pmid: 10644669
references.citation: Science. 1997 Aug 15;277(5328):955-9
references.pmid: 9252327
references.citation: J Clin Invest. 1990 Nov;86(5):1641-8
references.pmid: 2243137